Clinical Trials Browser

Phase 2 × Neoplasm, Residual × Radiotherapy × Clear all

NCT07517705 2026-05-13

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Phase 2 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual